Business · 18/07/2005
FDA Approves New Animal Drug for Skeletal Marking of Finfish Fry and Fingerlings
The FDA has approved a supplemental new animal drug application filed by Pfizer, Inc. for the use of oxytetracycline hydrochloride soluble powder in marking finfish fry and fingerlings through immersion.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →